Anti-CD33-CLL1 CAR-T Cells (ICG415) for the Treatment of Relapsed/Refractory Acute Myeloid Leukemia

Abroad (travel likely)RecruitingPHASE1

Conditions

Acute Myeloid Leukemia (AML)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Jiangxi Provincial People's Hospital (Participating Site), Nanchang, Jiangxi, China
Contact: Study coordinator (Cheng Hongbo) · 784260212@qq.com · +86 137 0708 5405
The First Affiliated Hospital of Nanchang University (Lead Site), Nanchang, Jiangxi, China
Contact: Study coordinator (Li Fei) · yx021021@sina.com · +86 139 7003 8386

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Acute Myeloid Leukemia · Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm · Acute Myeloid Leukemia Post Cytotoxic Therapy

Abroad (travel likely)RecruitingPHASE2

Birmingham, United States · Phoenix, United States

Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning

Acute Lymphoblastic Leukemia · Acute Myeloid Leukemia · Chronic Myelomonocytic Leukemia

Abroad (travel likely)RecruitingPHASE2

Duarte, United States

CD33-CAR T Cell Therapy for the Treatment of Recurrent or Refractory Acute Myeloid Leukemia

Acute Myeloid Leukemia · Recurrent Adult Acute Myeloid Leukemia · Refractory Acute Myeloid Leukemia

Abroad (travel likely)RecruitingPHASE1

Duarte, United States

uCD7 CART for Relapsed or Refractory CD7 Positive Hematologic Malignancies

Acute Myeloid Leukemia (AML) · T Lymphoblastic Leukemia/Lymphoma

Abroad (travel likely)RecruitingPHASE1

Tianjin, China